Summary & Overview
HCPCS P9060: Fresh Frozen Plasma, Donor Retested, Each Unit
HCPCS Level II code P9060 identifies a unit of fresh frozen plasma that has been donor retested prior to release. Fresh frozen plasma is a critical blood product used to manage coagulation disorders, massive transfusion protocols, and certain emergency and perioperative situations. Accurate coding for retested plasma units matters nationally because it supports appropriate claims processing, inventory tracking, and clinical supply management across hospital and transfusion settings.
Key payers examined include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical context and service settings, alongside practical billing considerations for institutional providers. The publication summarizes common modifiers and payer coverage patterns where available, highlights how this HCPCS Level II code fits into blood product billing workflows, and outlines benchmarks and policy considerations relevant to payers and hospital revenue stakeholders.
This overview is intended for national audiences involved in hospital billing, blood bank management, and payer policy. It provides the essential context needed to interpret claims that include P9060, clarifies typical sites of service, and points to areas where billing clarity and documentation support are important.
Billing Code Overview
HCPCS Level II code P9060 describes fresh frozen plasma, donor retested, each unit. This service represents a single unit of donor plasma that has been frozen for preservation and subsequently retested for infectious agents or other safety criteria prior to clinical use.
Service Type: Blood product transfusion / blood banking supply
Typical Site of Service: Hospital inpatient or outpatient settings, hospital blood bank, transfusion center, or other clinical sites where blood products are administered or dispensed.
Clinical & Coding Specifications
Clinical Context
A 62-year-old male with end-stage liver disease is admitted to the hospital with acute variceal bleeding and coagulopathy. Laboratory testing shows an elevated international normalized ratio (INR) of 2.8 and active bleeding despite initial resuscitation. The clinical team orders transfusion of fresh frozen plasma to replace deficient clotting factors while preparing for endoscopic hemostasis. The blood bank issues units labeled as P9060 (Fresh frozen plasma, donor retested, each unit). Units are verified at bedside by two licensed practitioners, transfusion consent is confirmed, and pre‑transfusion vital signs are recorded. During transfusion the patient is monitored for transfusion reactions; post‑transfusion INR is rechecked to assess response. Typical documentation includes blood product unit identifiers, indication (coagulopathy with active bleeding), volume infused per unit, start and stop times, and any reactions or complications.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Use when no specific modifier applies to the service. |
22 | Increased procedural services |